ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Feb 21, 2017
Insider Transaction Report
Form 4
Woosley Raymond L.
Director
Transactions
- Award
Stock Option (right to buy)
2017-02-16+8,000→ 8,000 totalExercise: $2.50Exp: 2027-02-15→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the 2013 Amended and Restated Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 1, 2017. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested.